Global Information
회사소개 | 문의

세계의 골이식 및 대체 골이식편 시장 예측

Global Bone Grafts and Substitute Market Forecast 2018-2026

리서치사 Inkwood Research
발행일 2018년 10월 상품 코드 574465
페이지 정보 영문 143 Pages
가격
US $ 2,500 ₩ 2,841,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 3,409,000 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. PDF 파일은 Copy & Paste가 되지 않습니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,113,000 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 골이식 및 대체 골이식편 시장 예측 Global Bone Grafts and Substitute Market Forecast 2018-2026
발행일 : 2018년 10월 페이지 정보 : 영문 143 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 골이식 및 대체 골이식편 시장에 대해 조사했으며, 시장 개요, 종류·응용 분야·채취/고정 디바이스별 시장 동향, 시장 규모 예측(향후 9년간), 시장 성장에 대한 각종 영향요인, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

제1장 조사 범위

제2장 조사 방법

제3장 개요

  • 시장 요약
  • 주요 조사 결과

제4장 시장 결정 요인

  • 촉진요인
  • 저해요인
  • 시장 기회
  • 과제

제5장 시장 세분화

  • 종류별
    • 자가이식편
    • 동종이식편
    • 합성 이식편
  • 응용 분야별
    • 척추 고정
    • 장골
    • 발·발목
    • 두개악안면
    • 관절 재건
    • 치과용 이식편
  • 채취·고정 디바이스
    • 합성 RIA
    • 이식편 홀더
    • 농축혈소판 혈장(PC) 시스템
    • 천공기용 어태치먼트
    • 골수천자시스템
    • 기타

제6장 시장 분석

  • Porter의 산업 분석
  • 주요 기업 분석
  • 주요 구매 기준

제7장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 스페인
    • 기타
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 호주
    • 기타
  • 기타 지역
    • 라틴아메리카
    • 중동·아프리카

제8장 기업 개요

  • 경쟁 구도
    • 시장 점유율 분석
    • 지역별 투자 기회
    • 새로운 시장 기회
    • 주요 전략
  • ALLOSOURCE, INC.
  • BAXTER INTERNATIONAL INC.
  • DEPUY SYNTHES, INC
  • INTEGRA LIFESCIENCES CORP
  • MATHYS EUROPEAN ORTHOPEDIC
  • MEDTRONIC, INC.
  • NUVASIVE INC.
  • ORTHOFIX HOLDINGS, INC.
  • SIGMAGRAFT
  • SMITH AND NEPHEW PLC
  • STRYKER CORPORATION
  • ZIMMER BIOMET HOLDINGS INC
  • WRIGHT MEDICAL GROUP N.V.
  • XTANT MEDICAL HOLDINGS, INC.
KSA 17.11.21

KEY FINDINGS

The global bone graft and substitute market is projected to increase between the forecast years of 2018-2026 at a CAGR of 5.25%. Factors like high demand for orthopaedic procedures, technological advancements and unhealthy lifestyle choices leading to a rise in degenerative joint diseases are boosting the market growth.

MARKET INSIGHTS

The global bone graft and substitute market is segmented on the basis of applications, types, and harvesting and fixation devices. The market finds its application in treatments involving long bone, spinal fusion, craniomaxillofacial, foot and ankle, dental, and joint reconstruction. The bone graft and substitute types include autografts, allografts, and synthetics and additives. The harvesting and fixation devices are further sub-divided into implant holder, synthes RIA, platelet concentrate system, bone marrow aspirate concentrate systems, trephine attachment tool, and other harvest devices.

REGIONAL INSIGHTS

The global bone graft and substitutes market is regionally segmented into North America, Asia-Pacific, Europe and Rest of World. The Asia-Pacific market is anticipated to be the fastest-growing market, driven by rising incidences of osteoporosis and osteoarthritis and a growing number of hip and knee replacement surgeries. However, the North American region is expected to lead the global bone graft and substitute market by the end of the forecast period on account of the high incidences of bone fractures requiring bone grafting treatment.

COMPETITIVE INSIGHTS

Some of the competing companies in the market include Allosource Inc, Baxter International Inc, Depuy Synthes Inc, Integra Lifesciences Corp, Medtronic, Nuvasive Inc, Orthofix Holdings Inc, Sigmagraft, Smith And Nephew Plc, Stryker Corporation, Zimmer Biomet Holdings Inc, Wright Medical Group N.V and Xtant Medical Holdings Inc.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
    • 2.1.3. TOP DOWN APPROACH
  • 2.2. BOTTOM-UP APPROACH
  • 2.3. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. SPINAL FUSIONS TO LEAD THE APPLICATION SEGMENT
    • 3.2.2. ASIA PACIFIC IS GROWING SIGNIFICANTLY
    • 3.2.3. ALLOGRAFT DOMINATES THE GLOBAL BONE GRAFT AND SUBSTITUTE MARKET

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVERS
    • 4.1.1. INCREASE IN TREATMENTS AND SURGERIES INVOLVING MUSCULOSKELETAL DISORDERS
    • 4.1.2. AGEING OF POPULATION IN KEY COUNTRIES
    • 4.1.3. INCREASING SOPHISTICATION OF BIOCOMPATIBLE SYNTHETIC BONE GRAFTS
    • 4.1.4. TECHNOLOGICAL ADVANCEMENTS
    • 4.1.5. UNHEALTHY LIFESTYLE CHOICES LEADING TO A RISE IN DEGENERATIVE JOINT DISEASES
    • 4.1.6. RISE IN SPINAL FUSION AND JOINT RECONSTRUCTION
    • 4.1.7. INCREASE IN DEMAND FOR ORTHOPEDIC PROCEDURE
  • 4.2. MARKET RESTRAINTS
    • 4.2.1. INCREMENTAL RISE IN THE COST OF SURGERIES
    • 4.2.2. ETHICAL ISSUES ASSOCIATED WITH BONE GRAFTING PROCEDURES
    • 4.2.3. THE STRINGENT REGULATORY APPROVAL PROCESS
  • 4.3. MARKET OPPORTUNITIES
    • 4.3.1. RESEARCH AND INVESTMENT IN BIOENGINEERING LEADING TO THE DEVELOPMENT OF HYBRID MATERIAL FOR BONE GRAFTING
    • 4.3.2. RISE IN REIMBURSEMENT FOR SURGERIES IN DEVELOPED NATIONS
  • 4.4. MARKET CHALLENGES
    • 4.4.1. SURGICAL RISK RELATED TO REJECTION DUE TO IMMUNE RESPONSE
    • 4.4.2. LIMITED SUPPLY AND HIGH DONOR SITE MORBIDITY RATE.FOR AUTOGRAPHS
    • 4.4.3. INCREASED SCRUTINY OF STEM CELL-DERIVED PRODUCTS
    • 4.4.4. OFF-LABEL USE OF BONE GRAFT MATERIAL
    • 4.4.5. HIGH COST OF BONE GRAFTING SURGERIES

5. MARKET SEGMENTATION

  • 5.1. MARKET BY TYPE 2018-2026
    • 5.1.1. ALLOGRAFT
    • 5.1.2. AUTOGRAFTS
    • 5.1.3. SYNTHETICS AND ADDITIVES
  • 5.2. MARKET BY APPLICATION 2018-2026
    • 5.2.1. SPINAL FUSION
    • 5.2.2. LONG BONE
    • 5.2.3. FOOT AND ANKLE
    • 5.2.4. CRANIOMAXILOFACIAL
    • 5.2.5. JOINT RECONSTRUCTION
    • 5.2.6. DENTAL BONE GRAFT
  • 5.3. MARKET BY HARVESTING AND FIXATION DEVICES 2018-2026
    • 5.3.1. SYNTHES RIA MARKET
    • 5.3.2. IMPLANT HOLDER
    • 5.3.3. PLATELET CONCENTRATE SYSTEM
    • 5.3.4. TREPHINE ATTACHMENT TOOL
    • 5.3.5. BONE MARROW ASPIRATE CONCENTRATED SYSTEM
    • 5.3.6. OTHER HARVEST DEVICES

6. KEY ANALYTICS

  • 6.1. PORTER'S FIVE FORCE ANALYSIS
    • 6.1.1. THREAT OF NEW ENTRANTS
    • 6.1.2. THREAT OF SUBSTITUTE PRODUCTS
    • 6.1.3. BARGAINING POWER OF BUYER
    • 6.1.4. BARGAINING POWER OF SUPPLIER
    • 6.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.2. KEY COMPANY ANALYSIS
  • 6.3. KEY BUYING CRITERIA
  • 6.4. OPPORTUNITY MATRIX

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. THE UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. THE UNITED KINGDOM
    • 7.2.2. FRANCE
    • 7.2.3. GERMANY
    • 7.2.4. SPAIN
    • 7.2.5. REST OF EUROPE
  • 7.3. ASIA-PACIFIC
    • 7.3.1. CHINA
    • 7.3.2. INDIA
    • 7.3.3. JAPAN
    • 7.3.4. AUSTRALIA
    • 7.3.5. SOUTH KOREA
    • 7.3.6. REST OF ASIA-PACIFIC
  • 7.4. REST OF WORLD (ROW)
    • 7.4.1. LATIN AMERICA
    • 7.4.2. MIDDLE EAST & AFRICA

8. COMPANY PROFILE

  • 8.1. COMPETITIVE ANALYSIS
    • 8.1.1. MARKET SHARE ANALYSIS
  • 8.2. ALLOSOURCE INC
    • 8.2.1. MARKET OVERVIEW
    • 8.2.2. PRODUCT PORTFOLIO
    • 8.2.3. SCOT ANALYSIS
    • 8.2.4. STRATEGIC INITIATIVES
  • 8.3. BAXTER INTERNATIONAL INC
    • 8.3.1. MARKET OVERVIEW
    • 8.3.2. PRODUCT PORTFOLIO
    • 8.3.3. SCOT ANALYSIS
    • 8.3.4. STRATEGIC INITIATIVES
  • 8.4. DEPUY SYNTHES INC
    • 8.4.1. MARKET OVERVIEW
    • 8.4.2. PRODUCT PORTFOLIO
    • 8.4.3. SCOT ANALYSIS
    • 8.4.4. STRATEGIC INITIATIVES
  • 8.5. INTEGRA LIFESCIENCES CORP
    • 8.5.1. MARKET OVERVIEW
    • 8.5.2. PRODUCT PORTFOLIO
    • 8.5.3. SCOT ANALYSIS
    • 8.5.4. STRATEGIC INITIATIVES
  • 8.6. MEDTRONIC
  • 8.7. INC.
    • 8.7.1. MARKET OVERVIEW
    • 8.7.2. PRODUCT PORTFOLIO
    • 8.7.3. SCOT ANALYSIS
    • 8.7.4. STRATEGIC INITIATIVES
  • 8.8. NUVASIVE INC.
    • 8.8.1. MARKET OVERVIEW
    • 8.8.2. PRODUCT PORTFOLIO
    • 8.8.3. SCOT ANALYSIS
    • 8.8.4. STRATEGIC INITIATIVES
  • 8.9. ORTHOFIX HOLDINGS, INC.
    • 8.9.1. MARKET OVERVIEW
    • 8.9.2. PRODUCT PORTFOLIO
    • 8.9.3. SCOT ANALYSIS
    • 8.9.4. STRATEGIC INITIATIVE
  • 8.10. SIGMAGRAFT
    • 8.10.1. MARKET OVERVIEW
    • 8.10.2. PRODUCT PORTFOLIO
    • 8.10.3. SCOT ANALYSIS
    • 8.10.4. STRATEGIC INITIATIVE
  • 8.11. SMITH AND NEPHEW PLC
    • 8.11.1. MARKET OVERVIEW
    • 8.11.2. PRODUCT PORTFOLIO
    • 8.11.3. SCOT ANALYSIS
    • 8.11.4. STRATEGIC INITIATIVE
  • 8.12. STRYKER CORPORATION
    • 8.12.1. MARKET OVERVIEW
    • 8.12.2. PRODUCT PORTFOLIO
    • 8.12.3. SCOT ANALYSIS
    • 8.12.4. STRATEGIC INITIATIVE
  • 8.13. ZIMMER BIOMET HOLDINGS INC
    • 8.13.1. MARKET OVERVIEW
    • 8.13.2. PRODUCT PORTFOLIO
    • 8.13.3. SCOT ANALYSIS
    • 8.13.4. STRATEGIC INITIATIVES
  • 8.14. WRIGHT MEDICAL GROUP N.V.
    • 8.14.1. MARKET OVERVIEW
    • 8.14.2. PRODUCT PORTFOLIO
    • 8.14.3. SCOT ANALYSIS
    • 8.14.4. STRATEGIC INITIATIVES
  • 8.15. XTANT MEDICAL HOLDINGS, INC.
    • 8.15.1. MARKET OVERVIEW
    • 8.15.2. PRODUCT PORTFOLIO
    • 8.15.3. SCOT ANALYSIS
    • 8.15.4. STRATEGIC INITIATIVES

TABLE LIST

  • TABLE 1 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY GEOGRAPHY 2018-2026 ( MILLION)
  • TABLE 2 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY TYPE 2018-2026 ( MILLION)
  • TABLE 3 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN ALLOGRAFTS BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 4 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN AUTOGRAFTS BY GEOGRAPHY 2018-2026 ( MILLION)
  • TABLE 5 GLOBAL BONE GRAFTS SUBSTITUTE MARKET IN SYNTHETICS AND ADDITIVES MARKET BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 6 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY APPLICATION 2018-2026 ( MILLION)
  • TABLE 7 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN SPINAL BY GEOGRAPHY 2018-2026 ( MILLION)
  • TABLE 8 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN LONG BONE BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 9 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN FOOT AND ANKLE BY GEOGRAPHY 2018-2026 ( MILLION)
  • TABLE 10 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN CRANOMAXILOFACIAL BY GEOGRAPHY 2018-2026 ( MILLION)
  • TABLE 11 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN JOINT RECONSTRUCTION BY GEOGRAPHY 2018-2026 ( MILLION)
  • TABLE 12 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN DENTAL BONE GRAFT BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 13 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY HARVESTING AND FIXATION DEVICES 2018-2026 ( MILLION)
  • TABLE 14 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN SYNTHES RIABY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 15 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN IMPLANT HOLDERBY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 16 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN PLATELET CONCENTRATE SYSTEM BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 17 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN TREPHINE ATTACHMENT TOOL BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 18 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN BONE MARROW ASPIRATE CONCENTRATED SYSTEM BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 19 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN OTHER HARVESTING DEVICE BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 20 NORTH AMERICA BONE GRAFT AND SUBSTITUTE MARKET BY COUNTRIES 2018-2026 ( MILLION)
  • TABLE 21 EUROPE BONE GRAFT AND SUBSTITUTE MARKET BY COUNTRIES 2018-2026 ( MILLION)
  • TABLE 22 ASIA-PACIFIC BONE GRAFT & SUBSTITUTE MARKET BY COUNTRIES 2018-2026 ( MILLION)
  • TABLE 23 REST OF WORLD BONE GRAFT AND SUBSTITUTE MARKET BY COUNTRIES 2018-2026 ( MILLION)

FIGURES LIST

  • FIGURE 1 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 2 PERCENTAGE DISTRIBUTION OF POPULATION AGED ABOVE 65 YEARS FOR 2015 & 2050
  • FIGURE 3 DIABETES INCIDENCE IN THE TOP 10 COUNTRIES IN 2016 (MILLION)
  • FIGURE 4 THE UNITED STATES BONE GRAFT AND SUBSTITUTE 2018-2026 ( MILLION)
  • FIGURE 5 CANADA BONE GRAFT AND SUBSTITUTE 2018-2026 ( MILLION)
  • FIGURE 6 THE UNITED KINGDOM BONE GRAFT AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 7 FRANCE BONE GRAFT AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 8 GERMANY BONE GRAFT AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 9 SPAIN BONE GRAFT AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 10 REST OF EUROPE BONE GRAFT AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 11 CHINA BONE GRAFT & SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 12 INDIA BONE GRAFT & SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 13 JAPAN BONE GRAFT & SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 14 AUSTRALIA BONE GRAFT & SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 15 SOUTH KOREA BONE GRAFT & SUBSTITUTE 2018-2026 ( MILLION)
  • FIGURE 16 REST OF ASIA-PACIFIC BONE GRAFT & SUBSTITUTE 2018-2026 ( MILLION)
  • FIGURE 17 LATIN AMERICA BONE GRAFT AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 18 MIDDLE EAST & AFRICA BONE GRAFT AND SUBSTITUTE MARKET 2018-2026( MILLION)
  • FIGURE 19 GLOBAL BONE GRAFT & SUBSTITUTE MARKET SHARE OF COMPANIES 2017 (%)
Back to Top
전화 문의
이용안내
 
BCC Research